Stay updated with breaking news from Daiqing Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A novel hydrogel developed by Johns Hopkins University researchers cured 100% of mice with aggressive brain cancer by combining anticancer drugs and antibodies to target lingering cancer cells and trigger an immune response against glioblastoma. Medication delivered by a novel gel cured 100% of m
Medication delivered by a novel gel cured 100% of mice with an aggressive brain cancer, a striking result that offers new hope for patients diagnosed with glioblastoma, one of the deadliest and most common brain tumors in humans.
Combining an anticancer drug with an antibody, researchers developed a novel gel that cured glioblastoma brain cancer in 100% of mouse models. The findings offer new hope in the fight against the most deadly form of brain cancer in humans. The gel triggers an immune response and, when the cancer was reintroduced, the immune system alone helped beat the cancer without additional medications.
The gel can reach areas that surgery might miss and current drugs struggle to reach to kill lingering cancer cells and suppress tumor growth